Differential regulation of IGF-II-induced IL-8 by extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinases in human keratinocytes

Biochemical and Biophysical Research Communications

Volumn 317, Issue 1, 2004, Pages 276-284

  Kim, Hye Jung ^a   Byun, Sung June ^a   Kim, Tae Yoon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

AP 1; ERK; IGF II; IL 8; NF B; p38; Psoriasis

Indexed keywords

DNA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE INHIBITOR; SOMATOMEDIN B; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; MUTANT; ONCOGENE SRC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PSORIASIS; SIGNAL TRANSDUCTION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE, TRANSFORMED; CELLS, CULTURED; DNA; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR II; INTERLEUKIN-8; KERATINOCYTES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSFECTION;

EID: 1642504335     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.042     Document Type: Article

References (54)

1. Barker J.N. The pathophysiology of psoriasis. Lancet. 338:1991;227-230.
2. Nickoloff B.J., Mitra R.S., Varani J., Dixit V.M., Polverini P.J. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am. J. Pathol. 144:1994;820-828.
3. Ettehadi P., Greaves M.W., Wallach D., Aderka D., Camp R.D. Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin. Exp. Immunol. 96:1994;146-151.
4. Elder J.T., Fisher G.J., Lindquist P.B., Bennett G.L., Pittelkow M.R., Coffeyr R.J. Jr., Ellingsworth L., Derynck R., Voorhees J.J. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science. 243:1989;811-814.
5. Bhushan M., McLaughlin B., Weiss J.B., Griffiths C.E. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br. J. Dermatol. 141:1999;1054-1060.
6. Creamer D., Jaggar R., Allen M., Bicknell R., Barker J. Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis. Br. J. Dermatol. 137:1997;851-855.
7. Detmar M., Brown L.F., Claffey K.P., Yeo K.T., Kocher O., Jackman R.W., Berse B., Dvorak H.F. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180:1994;1141-1146.
8. Walz A., Peveri P., Aschauer H., Baggiolini M. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem. Biophys. Res. Commun. 149:1987;755-761.
9. Strieter R.M., Kunkel S.L., Elner V.M., Martonyi C.L., Koch A.E., Polverini P.J., Elner S.G. Interleukin-8; A corneal factor that induces neovascularization. Am. J. Pathol. 141:1992;1279-1284.
10. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., Elner S.G., Strieter R.M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 258:1992;1798-1801.
11. Yatsunami J., Tsuruta N., Ogata K., Wakamatsu K., Takayama K., Kawasaki M., Nakanishi Y., Hara N., Hayashi S. Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung. Cancer Lett. 120:1997;101-108.
12. Schulz B.S., Michel G., Wagner S., Suss R., Beetz A., Peter R.U., Kemeny L., Ruzicka T. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. J. Immunol. 151:1993;4399-4406.
13. Foss H.D., Herbst H., Gottstein S., Demel G., Araujo I., Stein H. Interleukin-8 in Hodgkin's disease; Preferential expression by reactive cells and association with neutrophil density. Am. J. Pathol. 148:1996;1229-1236.
14. Anttila H.S., Reitamo S., Erkko P., Ceska M., Moser B., Baggiolini M. Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. J. Invest. Dermatol. 98:1992;96-101.
15. Singh R.K., Gutman M., Reich R., Bar-Eli M. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res. 15:1995;3669-3674.
16. Schröder J.M. Cytokine networks in the skin. J. Invest. Dermatol. 105:1995;20S-24S.
17. Nickoloff B.J., Karabin G.D., Barker J.N., Griffiths C.E., Sarma V., Mitra R.S., Elder J.T., Kunkel S.L., Dixit V.M. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am. J. Pathol. 138:1991;129-140.
18. Asadullah K., Docke W.D., Volk H.D., Sterry W. Cytokines and cutaneous T-cell lymphomas. Exp. Dermatol. 7:1998;314-320.
19. Bornscheuer E., Schröder J.M., Christopher E., Sticherling M. Interleukin-8 immunoreactivity in malignant tumours of the skin. Acta Derm. Venereol. 76:1996;210-213.
20. Tensen C.P., Vermeer M.H., van der Stoop P.M., van Beek P., Scheper R.J., Boorsma D.M., Willemze R. Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas. J. Invest. Dermatol. 111:1998;222-226.
21. Hansen E.R., Vejlsgaard G.L., Lisby S., Heidenheim M., Baadsgaard O. Epidermal interleukin 1 alpha functional activity and interleukin 8 immunoreactivity are increased in patients with cutaneous T-cell lymphoma. J. Invest. Dermatol. 97:1991;818-823.
22. Hansen E.R. Immunoregulatory events in the skin of patients with cutaneous T-cell lymphoma. Arch. Dermatol. 132:1996;554-561.
23. Wismer J.M., McKenzie R.C., Sauder D.N. Interleukin-8 immunoreactivity in epidermis of cutaneous T-cell lymphoma patients. Lymphokine Cytokine Res. 13:1994;21-27.
24. Xu S., Cwyfan-Hughes S.C., van der Stappen J.W., Sansom J., Burton J.L., Donnelly M., Holly J.M. Altered insulin-like growth factor-II (IGF-II) level and IGF-binding protein-3 (IGFBP-3) protease activity in interstitial fluid taken from the skin lesion of psoriasis. J. Invest. Dermatol. 106:1996;109-112.
25. Cohick W.S., Clemmons D.R. The insulin-like growth factors. Annu. Rev. Physiol. 55:1993;131-153.
26. Kim K.W., Bae S.K., Lee O.H., Bae M.H., Lee M.J., Park B.C. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res. 58:1998;348-351.
27. Brenner R.M., Nayak N.R., Slayden O.D., Critchley H.O., Kelly R.W. Premenstrual and menstrual changes in the macaque and human endometrium: relevance to endometriosis. Ann. N. Y. Acad. Sci. 955:2002;60-74. discussion 86-88, 396-406.
28. Gillitzer R., Berger R., Mielke V., Muller C., Wolff K., Stingl G. Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J. Invest. Dermatol. 97:1991;73-79.
29. Bancroft C.C., Chen Z., Dong G., Sunwoo J.B., Yeh N., Park C., Van Waes C. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. Clin. Cancer Res. 7:2001;435-442.
30. Mukaida N., Mahe Y., Matsushima K. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J. Biol. Chem. 265:1990;21128-21133.
31. Mahe Y., Mukaida N., Kuno K., Akiyama M., Ikeda N., Matsushima K., Murakami S. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J. Biol. Chem. 266:1991;13759-13763.
32. Yasumoto K., Okamoto S., Mukaida N., Murakami S., Mai M., Matsushima K. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J. Biol. Chem. 267:1992;22506-22511.
33. H.J. Kim, T. Kim, IGF-II-mediated COX-2 gene expression in Human Keratinocytes through extracellular signal-regulated kinase pathway, J. Invest. Dermatol. (pending revision)
34. Luger T.A., Schwarz T. Evidence for an epidermal cytokine network. J. Invest. Dermatol. 95:1990;100S-104S.
35. Nickoloff B.J. The cytokine network in psoriasis. Arch. Dermatol. 127:1991;871-884.
36. Nickoloff B.J. The immunologic and genetic basis of psoriasis. Arch. Dermatol. 135:1999;1104-1110.
37. Larsen C.G., Anderson A.O., Appella E., Oppenheim J.J., Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science. 243:1989;1446-1464.
38. Wraight C.J., White P.J., McKean S.C., Fogarty R.D., Venables D.J., Liepe I.J., Edmondson S.R., Werther G.A. Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides. Nat. Biotechnol. 18:2000;521-526.
39. Weninger W., Rendl M., Mildner M., Tschachler E. Retinoids downregulate vascular endothelial growth factor/vascular permeability factor production by normal human keratinocytes. J. Invest. Dermatol. 111:1998;907-911.
40. Mildner M., Weninger W., Trautinger F., Ban J., Tschachler E. UVA and UVB radiation differentially regulate vascular endothelial growth factor expression in keratinocyte-derived cell lines and in human keratinocytes. Photochem. Photobiol. 70:1999;674-679.
41. Wraight C.J., Murashita M.M., Russo V.C., Werther G.S. A keratinocyte cell line synthesizes a predominant insulin-like growth factor-binding protein (IGFBP-3) that modulates insulin-like growth factor-I action. J. Invest. Dermatol. 103:1994;627-631.
42. Wraight C.J., Werther G.A. Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line HaCaT. J. Invest. Dermatol. 105:1995;602-607.
43. Bonnekoh B., Wevers A., Geisel J., Rasokat H., Mahrle G. Antiproliferative potential of zidovudine in human keratinocyte cultures. J. Am. Acad. Dermatol. 25:1991;483-490.
44. Muller K., Prinz H. Antipsoriatic anthrones with modulated redox properties. 4. Synthesis and biological activity of novel 9,10-dihydro-1,8- dihydroxy-9-oxo-2-anthracenecarboxylic and -hydroxamic acids. J. Med. Chem. 40:1997;2780-2787.
45. Geilen C.C., Bektas M., Wieder T., Kodelja V., Goerdt S., Orfanos C.E. 1alpha,25-Dihydroxyvitamin D3 induces sphingomyelin hydrolysis in HaCaT cells via tumor necrosis factor alpha. J. Biol. Chem. 272:1997;8997-9001.
46. Michel G., Gailis A., Jarzebska-Deussen B., Muschen A., Mirmohammadsadegh A., Ruzicka T. 1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells. Inflamm. Res. 46:1997;32-34.
47. Taylor S.I. Molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes. 41:1992;1473-1490.
48. Van-Obberghen E. Signalling through the insulin receptor and the insulin-like growth factor-I receptor. Diabetologia. (Suppl. 2):1994;S125-S134.
49. Cheatham B., Kahn C.R. Insulin action and the insulin signaling network. Endocr. Rev. 16:1995;117-142.
50. Verrando P., Ortonne J.P. Insulin binding properties of normal and transformed human epidermal cultured keratinocytes. J. Invest. Dermatol. 85:1985;328-332.
51. Misra P., Nickoloff B.J., Morhenn V.B., Hintz R.L., Rosenfeld R.G. Characterization of insulin-like growth factor-I/somatomedin-C receptors on human keratinocyte monolayers. J. Invest. Dermatol. 87:1986;264-267.
52. Hodak E., Gottlieb A.B., Anzilotti M., Krueger J.G. The insulin-like growth factor 1 receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: correlation of increased expression with epidermal hyperplasia. J. Invest. Dermatol. 106:1996;564-570.
53. 2+ mobilization in antigen-stimulated mast cells. J. Leukoc. Biol. 65:1999;321-329.
54. Le Roith D., Bondy C., Yakar S., Liu J.L., Butler A. The somatomedin hypothesis. Endocr. Rev. 22:2001;53-74.